Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 45,070 shares at $1.10 ($50K) on 2023-01-09, disclosed to the SEC on 2023-01-11.
Seasonal sale ($50k) by CEO and President — this insider has traded JNCE in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.10 | 20,191 | $22K | 44.4% |
| 2 | $1.12 | 24,879 | $28K | 55.6% |
| Total | $1.11 avg | 45,070 | $50K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |
| JNCE | SELL | 2021-01-11 | $220K | — | Filing → |